New Delhi: Drug Controller General of India (DCGI) on Friday approved restricted emergency use of Zydus Cadila's ‘Virafin’, Pegylated Interferon alpha-2b (PegIFN) in treating moderate COVID-19 infections in adults. The approval ...
New Delhi: The Serum Institute of India (SII) has sought emergency use authorisation of its vaccine candidate Covishield in the country. The Pune-based SII is conducting the India trials of ...
New Delhi: Pfizer India has become the first pharmaceutical firm to seek emergency use authorisation for its COVID-19 vaccine candidate in the country. The company has sought permission from the ...
Copyright © 2025 Frontier Media
